Ourofino Saúde Animal
Ourofino Saúde Animal, a prominent player in the animal health industry, is headquartered in Brazil and operates extensively across Latin America. Founded in 1985, the company has established itself as a leader in veterinary pharmaceuticals and nutritional products, focusing on the health and well-being of livestock and companion animals. With a diverse portfolio that includes vaccines, antiparasitics, and nutritional supplements, Ourofino Saúde Animal is recognised for its commitment to innovation and quality. The company’s unique approach combines advanced research with practical solutions tailored to the needs of farmers and pet owners alike. Ourofino has achieved significant milestones, including numerous awards for its contributions to animal health, solidifying its market position as a trusted partner in the agricultural sector.
DitchCarbon Score
How does Ourofino Saúde Animal's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ourofino Saúde Animal's score of 20 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ourofino Saúde Animal's reported carbon emissions
In 2023, Ourofino Saúde Animal reported total carbon emissions of approximately 5,155,980 kg CO2e, comprising 5,155,980 kg CO2e from Scope 1 and 27,790 kg CO2e from Scope 2, along with 965,500 kg CO2e from Scope 3 emissions. This marks a notable decrease from their 2022 emissions, which totalled about 7,966,640 kg CO2e, primarily driven by a reduction in Scope 1 emissions. Over the years, the company has experienced fluctuations in its emissions. In 2021, total emissions reached approximately 6,147,280 kg CO2e, while in 2020, no emissions data was reported. The highest recorded emissions were in 2022, with significant contributions from Scope 1 emissions at 7,966,640 kg CO2e. Despite these figures, Ourofino Saúde Animal has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company continues to monitor its emissions and aims to improve its sustainability practices within the animal health industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 2,539,110 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 2,035,310 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000 | 00,000 |
| Scope 3 | - | - | - | 000,000 | - | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ourofino Saúde Animal is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
